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The binding of anti-immunoglobulin (Ig) to the surface Ig receptors of the B 
lymphocyte sets  into  motion a  train  of events:  the complexes of membrane- 
bound Ig and anti-Ig antibody rapidly form disseminated patches which then 
aggregate into a cap at a polar end of the cell in an energy-requiring step (1-4). 
The complexes are subsequently endocytosed, an interval of a few hours elaps- 
ing before the cell synthesizes and replaces new molecules on its surface (5). 
Unique to the anti-Ig ligand is the parallel stimulation of translational motility 
shortly after the cap has formed (6, 7). This motility is susceptible to modulation 
by cyclic nucleotides and cholinergic and adrenergic agents (8). 
The nature of the energy-dependent event involved in capping has not been 
elucidated but is thought to be related to the activation of intracellular struc- 
tures involved in this process.  A  series of studies on various cells suggest a 
relationship  between surface interactions,  or ligand-receptor complexes,  and 
cytoplasmic structures (9,  10). For example, morphological studies on macro- 
phages have suggested a  role for microfilaments in membrane movement and 
endocytosis (discussed in Reference 11). In capping of lymphocytes, the adverse 
effects of  cytochalasin, albeit variable and not extensive, have suggested involve- 
ment  of the  microfilament system  in  the  phenomenon  (10). Also,  there  is 
morphological evidence of increased microfilaments in the area of the cap (10, 
12). Colchicine-sensitive structures, microtubules, likewise, have been thought 
to play some regulatory role in surface modulatory events (9, 13). Microtubules 
appear to affect capping of some surface complexes, implying some form of direct 
control by these structures (9, 12,  13), the nature of which is unclear. 
The rapid onset of the phenomena of capping and stimulated movement by 
anti-Ig antibodies in B lymphocytes led us to a consideration of a possible role for 
ions as stimulators or modulators in capping and motility. The inhibitory effects 
on cap formation of microfilament-affecting drugs, such as the cytochalasins, 
and the postulated role of  microfilaments in cell motility led our initial investiga- 
tions into the examination of the effects of calcium modulation on cap formation. 
We have utilized an experimental antibiotic, A-23187,  that forms lipid-soluble 
complexes with divalent cations, facilitating their transmembrane diffusion (14, 
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15).  Its calcium transporting property has been shown to stimulate a variety of 
calcium-dependent cell processes (16-19). 
In  this  report,  we  describe  the  role  of calcium  and  an  apparent  calcium- 
sensitive mechanism for cytoplasmic control of seemingly membrane-restricted 
events.  We  show that capping  and motility in the lymphocyte  do not require 
extracellular  calcium.  More  importantly,  we  describe  the  disruption  of the 
complexes in the cap by the calcium ionophore A-23187 in a calcium- and energy- 
requiring process.  This  latter  effect focuses on the possibility of a  direct  link 
between surface complexes and the contractile elements of the cell. 
Materials and Methods 
Cell Preparation.  Lymphocytes were obtained by teasing cells from the spleens of A/St mice 
(West Seneca Laboratories, Buffalo, New York), purifying them in Ficoll-Hypaque gradients, and 
collecting only the interface. The collected cells, over 98% viable lymphocytes, were washed twice. 
The medium was usually Hanks' balanced salt solution with 10 mM n-2-hydroxyethylpiperazine- 
N-2 ethane sulfonic acid (HEPES)  (Microbiological Associates,  Bethesda, Md.) and 2% fetal calf 
serum (Associated Biomedic Systems,  Inc.,  Buffalo, New York).  Experiments with calcium-free 
medium employed minimal essential medium without calcium with 10 mM HEPES and 2% fetal 
calf serum dialyzed against phosphate-buffered saline (PBS)  1 for 3 days. 
Antiserum.  The preparation and specificity of both the rabbit antimouse Ig (anti-Ig) and its 
fluorescent conjugate have been described in previous experiments (7, 8). They contain antibodies 
to  all  mouse  Fc  classes  and to  Fab  determinants.  One  set of experiments used  a  fluorescent 
conjugate of goat antiserum to rabbit Ig (GARG),  whose preparation  has also been previously 
described (8). 
Analysis of Capping  of Ig-Anti-Ig Complexes.  Unless the use of anti-Ig is noted specifically, 
fluorescein-conjugated rabbit anti-Ig (FITC-anti-Ig) was added to lymphocytes at a concentration 
of 50 ~g per 5 x  108 cells (in 0.5 ml) at 4°C (unless otherwise noted) for 20 min. The cells were then 
washed once and resuspended at a  concentration of 107 cells per ml. For the experiments on the 
morphology of capping, the cells were brought at 37°C for varying lengths of time before fixation 
by the addition of an equal volume of 2% paraformaldehyde. The fixed cells were then washed 
twice and resuspended in PBS. 
Two kinds of experiments were done; one was to test the effects of calcium deprivation, A-23187, 
etc., on capping and a second was to test the effects on the already formed cap. In experiments on 
the ionophore's effects on capping, 5 ×  10  e lymphocytes in 0.5 ml were incubated for 5 min at room 
temperature  in  medium containing the drug.  After preincubation,  50 /~g of FITC-anti-Ig was 
added  and  the  reaction  was  maintained  at  20  °  C  for  another  20  rain  before  the  addition  of 
paraformaldehyde. In experiments with colchicine, lymphocytes were preincubated in colchicine 
( 10  -4 M) for I h at 37°C, cooled to 20°C for 10 rain, exposed to FITC-anti-Ig, and allowed to cap for 20 
min. 
The experiments on the effect of either the ionophore or the cytochalasins on the formed cap 
were carried out by warming the FITC-anti-Ig-bound cells, after washing, to 20°C in a water bath 
(Forma Scientific, Inc., Marietta, Ohio). (We chose this temperature for several reasons. At 37°C, 
capping and subsequent endocytosis of complexes is extremely rapid [Fig. 1]. Cells cap well at 20°C 
but more slowly, an experimental condition that may help to minimize such factors as the rate of 
diffusion of a  drug into a  cell, which may occur too slowly to affect the capping phenomenon at 
37°C. Also, as has been noted, endocytosis appears to be preferentially inhibited for a long period of 
time when the cell is maintained at 20°C [12],  although it ultimately occurs [in about 1 h]; thus, 
the surface molecules are retained longer on the membrane for experimental manipulation.) By 
15-20 rain at  20°C,  approximately  55-90%  of the Ig-bearing cell are  capped.  After  15-25  min, 
specified in the text, reagents were added to tl~e reaction maintained at 20°C for another 15-25 min 
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before fixation  by the  addition  of paraformaldehyde.  In experiments  to  determine  whether 
ionophore-disrupted caps remained on the surface, cells were capped by adding nonlabeled anti-Ig 
in the same protocols as above. After fixation and washing, the cells were then exposed to FITC- 
GARG (100 ~l per 107 cells for 30 min at 4°C) and washed again.  In some experiments cells were 
examined directly under the microscope, as detailed before (8). 
Lymphocytes were examined  at a  400 magnification on a Leitz microscope with  fluorescent 
epiillumination.  In several experiments,  caps were graded according to the fraction of the cell 
surface stained by the fluorescent ligand. In experiments reporting results only in terms of caps, 
we have defined a cap as fluorescent staining covering less than one-half the cell surface. Unless 
otherwise specified, results are percentages of a minimum of 200 positively stained cells. Viability 
of lymphocytes was estimated by exclusion of trypan blue. 
Reagents.  The ionophore A-23187 was a gift from the Eli Lilly Co., Indianapolis, Ind. It was 
dissolved in dimethylsulfoxide (DMSO) at a concentration of 10 mg per ml, and serial dilutions in 
PBS were made from this stock. Appropriate dilutions of DMSO alone had no effect on capping. 
(The experiments reported in this paper were all done with a single batch of ionophore. A second 
batch,  received just recently,  gives us  identical  results  but requires  a  dose about  four times 
higher.) Cytochalasin D was a kind gift from Dr. Gabriel Godman (Columbia University College of 
Physicians and Surgeons, New York). Cytochalasin B, obtained from Aldrich Chemical Co., Inc., 
Milwaukee, Wis., was dissolved in DMSO at a concentration of 1 mg per ml and stored frozen; 
serial dilutions in medium were made as needed. Cytochalasin D was dissolved in PBS with 10% 
DMSO at a concentration  of i00 ~g per ml, stored at 4°C, and added directly to the reaction as 
needed. Sodium azide (Na azide), sodium cyanide (NaCN), and oligomycin were obtained  from 
Matheson, Coleman,  & Bell, East Rutherford,  N.J., Fisher  Scientific Co., Pittsburg,  Pa., and 
Sigma Chemical  Company, St.  Louis,  Mo., respectively.  Colchicine and ethyleneglycol-bis(B- 
amino-ethyl ether)N,N'-tetra-acetic  acid (EGTA) were obtained from Sigma Chemical Company 
and diluted in medium to a final concentration of 10  -4 M and 2 x 10  -3 M, respectively. 
Results 
Relationship  Between Capping and Changes in Cell Shape.  We first report 
on a time-sequence study on the development of the cap and its relationship with 
the change in cell shape.  FITC-anti-Ig antibody was added to murine  splenic 
lymphocytes at 4°C and allowed to bind for 20 min. The cells were spun, washed, 
and portioned in several tubes,  then allowed to settle  and brought to 37°C for 
varying lengths of time before fixation in 2% paraformaldehyde.  Fig.  1 shows 
the results of one such experiment. After binding in the cold, all the Ig-bearing 
cells were diffusely stained, appearing as rings whose surface was covered with 
small patches of fluorescence.  The subsequent reorganization of these  surface 
patches at 37°C was extremely rapid. After 1 min at 37°C the number of diffusely 
stained cells dropped to 36%  and thence to 4% after 2.5 min as the complexes 
redistributed  into  caps.  In  the  caps,  the  patches  aggregated  in  an  orderly 
fashion, covering successively less of the cell's surface.  17%  of the cells after 1 
min had caps covering one-half of the cell's surface; this percentage peaked at 
31% after 1.5 min and the dropped as the caps progressively coalesced into tight 
caps  covering less  than  one-fourth of the  cell  membrane.  The  percentage  of 
tightly capped cells rose rapidly to 60% after 2 min and was virtually complete at 
90% after 4 min.  Changes in cell shape took place in a  high percentage of cells 
after  the  development of caps.  The  most  striking  change  was  a  constriction 
taking place in the cytoplasm just below the area of the cap (see also Fig. 3 A, 3 
B,  and 5).  Note in Fig.  1 that by 2 min most cells have tight caps and yet the 
constriction has not developed until  about 30 s later.  A  second early change in 
shape was a small cytoplasmic and transient protrusion in the form of one or two 18  CALCIUM  EFFECTS  ON  CAPPING 
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FIG.  1.  The explanation of this experiment is in the text. The capping of cells with FITC- 
anti-Ig was stopped by fixation at the times given and the extent of the cap (read as percent 
of the cell surface covered by fluorescent staining) and the associated changes of morphology 
were evaluated microscopically. 200 positively stained cells were counted at each time. 
or three small spikes always opposite the cap. The thin spike was seen in cells 
with or without constriction at 2-3  min in time. After the constriction, other 
changes in cell shape,  notably, pseudopod formation, took place.  These have 
been described in past studies in more detail and correlated with a true, albeit 
limited,  translatory  motion  (6-8).  The  direction  of cytoplasmic flow  into  a 
pseudopod was always opposite to the cap.  Similar sequence of changes was 
observed  by  direct  microscopic  examination of cells  mounted  in  slides  and 
examined under a  curtain of 37°C air. Finally endocytosis followed cap forma- 
tion starting at about 4 min. In essence, this kind of detailed study reaffirmed 
previous conclusions of two interrelated but separated events: the cap and the 
changes in shape (6, 7).  We emphasize here the first evidence of gross contrac- 
tion in the cell occurring past the capping event and in a topography close to the 
cap area. 
The Role of Calcium in Capping.  The role of calcium was studied in two 
ways. Firstly, cells underwent ligand binding and capping in an environment 
depleted of calcium either through the use of calcium-free medium or by the 
addition of varying concentrations of EGTA, a specific calcium-chelating agent 
which, at 2 mM, remains extracellular (20). Secondly, cells were preincubated 
with varying doses of A-23187.  The results are shown in Table I  and Fig.  2. 
Depleting the extracellular environment of calcium had no inhibitory effect on 
the cell's ability to cap. The introduction of calcium into the cytoplasm by low 
doses of the ionophore produced a striking inhibition of capping. Cells to which 
as little as 0.1  ~g per ml of A-23187 was added manifested diffusely scattered 
patches of fluorescence over the entire cell surface throughout the course of the 
experiment.  A-23187 inhibited capping at doses  not toxic to the  cells  which 
remained perfectly viable. With this batch of A-23187, toxic effects were seen at 
doses of 2 ~g per ml or more (approximately 30% death). Calcium-free medium 
or the presence  of EGTA in calcium-containing medium completely reversed 
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TABLE  I 
Effects of Calcium on Capping 
Media 
Percent of caps 
Experi-  Experi-  Experi-  Experi- 
ment 1  ment 2  ment 3  ment 4 
Control--no treatment  76  79  65  76 
Calcium-free medium  --  80  --  76 
2 mM EDTA  88  68 
A-23187 
0.002 ~tg per ml  --  --  50  54 
0.01 ~g per ml  --  --  25  32 
0.10 ~g per ml  --  --  6  7 
A-23187 (0.10/~g per ml)  --  --  --  68 
plus 2 mM EDTA 
A-23187 (0.10/~g per ml) in 
calcium-free medium 
67 
5  x  I0  e lymphocytes in 0.5 ml were incubated for 5 min at room temperature in the 
different media. After 5 min at room temperature, 50/~g of FITC-anti-Ig were added 
and  the reaction  allowed  to  proceed  a  further 20  min at room temperature  before 
termination  with  paraformaldehyde.  In  experiments  with  A-23187,  the  ionophore 
was  added  during  the  preincubation  and  remained  throughout  the  reaction.  In 
experiments with EGTA, EGTA was also present throughout the preincubation and 
incubation periods.  Results are expressed as percent of positively stained cells with 
caps. 
(Fig.  2). The ionophore also prevented the changes in shapes of the B lympho- 
cyte, maintaining it in a rounded, immobile position. This inhibition,  too, could 
be reversed by chelating extracellular calcium.  In experiments to be published 
we have confirmed the entrance of calcium into the lymphocyte by A-23187 using 
45Ca" 
The Effect of Calcium Influx on the Formed Cap.  If the influx of calcium was 
acting  to  functionally  immobilize  molecules  presumably  floating  in  a  lipid 
matrix, it was possible to hypothesize some potential cytoplasmic link, activated 
by calcium,  to those molecules in whatever pattern they are organized on the 
cell  membrane.  Hence,  we investigated  the  effects of an  ionophore-mediated 
calcium influx on Ig caps. 
As outlined  in  Materials  and  Methods,  cells exposed to FITC-anti-Ig  were 
allowed to form caps for 25 min at 20°C. The ionophore A-23187 was then added 
for another  15 min,  at which time the reaction was ended by the addition of 
paraformaldehyde.  Table II contains the representative results of two of seven 
experiments. 
In Experiment 1, 89 and 91% of the control lymphocytes formed caps covering 
one-half or less of the cell surface after 25 min at 20°C. In Experiment 2, 76% of 20  CALCIUM  EFFECTS  ON  CAPPING 
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Fro.  2.  FlTO-anti-lg ws added to lymphocytes  at room  temperature in calcium-containing 
medium after preincubation for 5 rain at room temperature. To half the cells, A-23187 
(O-  -  -0)  was added during the preincubation and was present throughout the reaction. To 
the other half, A-23187 was added to lymphocytes  in medium plus 2 mM EGTA (C---O); 
the rest of  the protocol  was the same. The reaction was terminated 20 min after the addition 
of anti-Ig. Results are expressed as percentage of capped cells in 200 positively stained 
lymphocytes. 
the control cells capped under the same conditions. In both experiments, the 
percentage of  capped cells rose slightly after a further 15-min incubation at 20°C. 
The addition of A-23187  not only stopped this slight rise,  but it also actively 
disrupted the caps, dispersing fragments of the cap over the entire cell surface. 
In both experiments, 60-80% of the cells became diffusely stained.  The iono- 
phore broke the cap into irregularly sized fragments covering 75-100% of  the cell 
surface (Fig. 3). An occasional cell showed partial fragmentation of the cap. The 
cells that remained capped in the presence of the ionophore were those that had 
formed very tight caps that were beginning to undergo endocytosis. In further 
experiments, we found that, under conditions that stimulated endocytosis, the 
disruptive effect of the ionophore, though present, was muted. In one of three 
such experiments, we allowed the cell to cap at 25°C for 15 min, at which point 
92% of the Ig-bearing cells capped. The ionophore was added at a  0.2 ~g per ml 
dose and the reaction taken to 37°C for 2 min. In the presence of the ionophore, 
61% of the cells remained tightly capped, and 39% were diffused stained. Most of 
the tightly capped cells were in the midst of actively endocytosing their com- 
plexed Ig receptors. Allowing the  reaction to proceed longer at  37°C did  not 
markedly enhance the ionophore effect. Thus, there appears to be a  tempera- 
ture-sensitive end stage of cap formation in which the surface molecules are no 
longer sensitive to an influx of calcium. 
The calcium specificity of the ionophore effect is demonstrated in Fig. 4. The 
cells were exposed to A-23187 as before, but in the presence or absence of EGTA. 
In the presence of 2 mM EGTA, the ionophore did not disrupt the caps at any of 
the dosages studied. The cells were able to maintain their caps for the duration 
of the experiment. 
To be sure that the complexes disrupted by the ionophore were on the cell 
surface, we carried out experiments using nonlabeled anti-Ig, detecting it by use GEORGE  F.  SCHREINER  AND  EMIL  R.  UNANUE  21 
TABLE II 





Extent of cap* 
Untreated cells 
25min  40min 
Cells after addition 
of A-23187 
0.2 
O. 1 p~g/ml  /zg/ml 
% 
One-fourth  86  82  91  96  11  17 
One-half  5  7  4  0  5  4 
Three-fourths  4  4  2  0  10  4 
No cap  5  7  3  4  74  75 
One-fourth  68  75  25  24 
One-half  8  4  7  4 
Three-fourths  6  3  4  2 
No cap  18  18  64  70 
* Expressed as fraction of cell surface stained by fluorescent ligand.  50  pg FITC-anti-Ig were 
added to 5 x  i08 lymphocytes in 0.5 ml at 4°C for 20 min. The cells were then washed, warmed to 
20°C, and allowed to cap for 25 rain. A-23187 was then added and the reaction allowed to proceed 
a further 15 rain. Each result represents one tube when 200 positive cells were counted. 
of a fluorescent GARG. That is to say, cells treated with rabbit anti-Ig, capped, 
and exposed to the ionophore were then stained with the labeled GARG in the 
cold. The experiments verified that the complexes of anti-Ig-Ig were on the cell 
surfaces,  inasmuch  as  they  could  be  detected  by the  labeled  antibody  in  a 
sandwich reaction (Table III). 
The Effect of Metabolic Inhibitors on the Formation and Maintenance of the 
Cap and on the Calcium-Sensitive Disruption of the Cap.  We investigated the 
effects of metabolic inhibitors  on the formation of the cap, the maintenance  of 
the formed cap, and on the disruptive effect of the ionophore-mediated calcium 
influx.  One of three experiments is presented in Fig.  5. Fig. 5 A  demonstrates 
the effect of these metabolic inhibiters on the formation of the cap. FITC-anti-Ig 
was added to the cells in the cold. After washing, the cells were brought to 20°C 
at the same time that the metabolic inhibitors were added to the concentrations 
shown. The reaction was terminated after 20 min by the addition ofparaformal- 
dehyde, at which time 71% of cells not treated with any drug had capped their 
surface Ig receptors. The presence of sodium azide, sodium cyanide, or oligomy- 
cin blocked cap formation in agreement with past experimental results (1, 2, 4). 
In Fig. 5 B, after binding FITC-anti-Ig and being washed, cells were allowed to 
cap  for  20  min  at  20°C;  metabolic  inhibitors  were  added  at  20  min  and  the 
reaction allowed to proceed for another  20 min.  To cells with and without the 
drug present,  0.05 ~g of the  ionophore A-23187  was added at 25 min and was 
present for the  last  15 min  of incubation  at  20°C.  The  presence of metabolic 
inhibiters  alone did not affect the capped cells,  which,  in other experiments, 
remained intact after more than an hour's incubation in these compounds. Most 
interestingly,  cells to which metabolic inhibitors  were added 5 min before the 22  CALCIUM  EFFECTS  ON  CAPPING GEORGE  F.  SCHREINER  AND  EMIL  R.  UNANUE  23 
addition  of the  ionophore  experienced  little  or no  disruption  of their  capped 
complexes.  We  concluded  that  the  calcium-mediated  reversion  of Ig  caps  is 
dependent upon metabolic energy. 
We noted that some of the cells with caps treated with metabolic inhibitors (in 
the absence of A-23187) had a  marked exaggeration  of their constriction ring. 
Fig.  6  b  and  c  demonstrate  the  appearance  of capped cells  which  have  been 
incubated in oligomycin, 2/~g per ml, after cap formation. The cells resemble an 
"apple core," with a severely constrictive band directly in front of the cap that 
appears to be forcing the cytoplasm in front to splay out. Similar observations 
were made on cells in azide and cyanide.  We explain this phenomenon to be a 
form of rigor mortis analogous to an ATP-deprived actomyosin system. 
The Effect of Cytochalasins  on the Formed Cap.  We have investigated the 
effect of cytochalasins B and D on the disruption of the caps. Table IV contains 
the results of two experiments in which cells were allowed to cap for 20 min at 
20°C before the addition of the cytochalasins for the last 20 min of the reaction, 
also at 20°C.  One set of cells was preincubated with colchicine,  10  -4 M, for 1 h 
before  the  addition  of the  ligand  and  the  cytochalasins.  Cytochalasin  B  had 
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FIG.  4.  Cells exposed to FITC-anti-Ig were allowed to cap for 20 rain at 20°C in the absence 
or presence of 2 mM EGTA,  which had no effect on cap formation by itself. A-23187 was 
added at 20 rain, and the reaction was terminated 20 min later. In the left panel, the results 
are expressed as percentage of 200 positively stained cells manifesting caps at the end of the 
reaction. In the right panel, the same data has been expressed as percentage of capped cells 
at 20 rain that have undergone cap disruption (fluorescent staining covering 75-100% of the 
cell surface) by the end of the reaction. 
Fro.  3.  (A  and  B)  These  figures  show  positively  stained  cells  from  the  control  group 
allowed to cap a  total of 40 min at 20°C.  The lower left-hand cell in A  is a  cell that never 
capped; note the diffuse staining organized in micropunctate patches. The upper right-hand 
cell in A and the cell in B have capped. The arrow points to the constriction frequently seen 
encircling the cell  and delimited by the cap.  The small white dots mark the edges  of the 
unlabeled membranes. (C, D, and E) These figures show cells that were allowed to cap for 25 
rain and to which the ionophore A-23187 (0.1 ~g per ml) was added for a further 15 min at 
20°C.  Cells  with disrupted caps  manifest diffuse  staining  in irregularly sized fragments 
covering most of the cell surface. 24  CALCIUM  EFFECTS  ON  CAPPING 
TABLE  III 
Effect ofA-23187 on Cells Capped with Anti-Ig or FITC-anti-Ig 
Extent of cap* 
Untreated cells  Cells  +  A-23187 
20 min  35 min  0.1 ~g/ml  0.2 ~g/ml 
FITC-anti-Ig 
1/4  50  51  68  71  12  14  14  8 
1/2  14  14  12  8  3  5  7  9 
3~  6  7  1  1  2  4  4  3 
No cap  30  28  19  20  83  77  75  80 
Anti-Ig +  FITC-GARG 
1/4  57  57  72  67  19  19  8  9 
1/2  17  10  11  10  5  10  4  8 
3/4  3  5  2  4  7  8  6  1 
No cap  23  28  15  19  69  63  82  82 
50 p,g of either anti-Ig or FITC-anti-Ig were added to 5  ×  10  e lymphocytes at 4°C for 20 min. The 
cells were washed and warmed to 20°C for 20 rain. A-23187 was then added to both preparations 
at the concentrations noted for another 15 min. After fixation and washing, cells treated with 
anti-Ig were exposed to FITC-GARG (100 tzl/107 cells for 30 min at 4°C) and then washed. Results 
for duplicate tubes are expressed as percentage of 200 positively stained cells. 
* Expressed as fraction of cell surface stained by fluorescent ligand. 
presence of colchicine, as has been observed (12). Cytochalasin D was a powerful 
disrupter of Ig caps by itself. Also, the caps disrupted by cytochalasin D were 
more diffuse than those fragmented by cytochalasin B. Colchicine not only had 
no synergistic effect, but appeared to inhibit somewhat the extent of the cyto- 
chalasin-induced  reversion of the cap.  Colchicine,  alone,  had no effect on caps 
(data not shown). 
Discussion 
The progression  from the  aggregation  of molecules into  a  cap through  the 
stage of cell movement to endocytosis and catabolism of the complexes is orderly 
and  rapid.  Frequently,  visible  around  the  edge  of the  shrinking  cap  is  an 
encircling contractile band that ultimately may force the cytoplasm to stream in 
the  direction  opposite to  that  of the  now  tightly  aggregated  cap.  Thus,  the 
polarity induced by the position of the cap appears in some part to determine the 
asymmetrical  contraction  necessary  for  translational  motility.  We  have  ob- 
served a calcium-activated cytoplasmic modulation of the aggregation of patches 
of Ig complexes in the plane  of the membrane  and their  maintenance  in cap 
structure. The ionophore-mediated influx of calcium prevents capping. Further- 
more, the calcium ionophore produces a  striking effect in that it fragments and 
disperses the capped complexes across the surface of the cell. While cap forma- 
tion and lymphocyte motility are not affected by the deletion of calcium from 
the extracellular  medium,  the inhibitory and disruptive effects of A-23187  are 
completely abrogated by the presence of the calcium-chelating EGTA. Once the 
cap is constituted, its maintenance  is not dependent upon further consumption 25 
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FIG.  5.  (A) The explanation of the experiment is in the text. Na azide, NaCN, or oligomy- 
cin were added to FITC-anti-Ig-bound  lymphocytes as they were warmed from 4°C to 20°C. 
Results are expressed as inhibition of cap formation, in which the number of capped cells in 
200 positively stained  lymphocytes  is calculated  as percentage  of the capped  cells  in the 
control group (71%) and subtracted from one. (B) The experiment is explained in the text. It 
shows the disruption of caps by treatment with ionophore,  metabolic inhibitors, or both in 
combination.  Results  are  expressed  as  the  percentage  of capped  cells  in  200  positively 
stained lymphocytes. 
of metabolic  energy,  although  subsequent  endocytosis  is  (5).  The  disruptive 
effect  of  the  calcium  influx  on  capping  is  apparently  dependent  upon  the 
avaliability of ATP. 
We  feel  that  the  requirements  for  extracellular  calcium  and for  metabolic 
energy  for  disruption  of the  cap  by  the  ionophore  can  best  be  explained  by 
postulating an effect on the contractile  elements  of the lymphocyte.  Previous 
experiments on the effects of capping by cytochalasin B (1, 10) also suggested the 
involvement of microfilaments,  but were  somewhat inconclusive  inasmuch  as 
the exact mode of action of the drug was not clear, and the effects seen were not 
extensive, requiring large doses and the synergistic effects of colchicine (12, 21, 
22). Recent studies using cytochalasin D strongly suggest that this drug, in fact, 
produces  a  marked  aggregation-contraction  of the  microfilament  network  of 
the  cell  cortex  in  an  energy-requiring  step  (23,  24).  This  drug  inhibits  cap 
formation  2 and, as was shown herein, also disrupts the cap. Both the effects of A- 
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23178 and cytochalasin D could be interpreted on the basis that they produce a 
systemic hypercontractile state of the microfilaments.  An alternative  explana- 
tion is that both these drugs directly affect the plasma membrane, dislodging in 
some way the cap. The calcium and energy requirement for A-23187 to break the 
cap tends to argue against this. The mechanisms of cap disruption described by 
de Petris (12) and discussed later may involve, however, a  different process. 
We wish to offer a working hypothesis to explain much of what we and others 
have described and to provide a  guide to further investigation.  Available evi- 
dence suggests that there is a calcium-responsive system in the cytoplasm that 
modulates beth the formation and the maintenance of the Ig cap. The identifica- 
tion  of the  microfilament  network  in  the  cytoplasm  as  responsible  for  the 
generation  of contractile  force in  many cell  systems (11,  23,  25-27)  has  been 
TABLE  IV 
Effect of Cytochalasins on Caps 
Experiment 1  Experiment 2 
% 
Untreated cells 
at 20 min  81  82 
at 40 min  83  94 
Cytochalasin B, 20 ~g/ml  52  48 
Cytechalasin B, 20 ~g/ml  19  37 
+  colchicine, 10  -4 M 
Cytochalasin D, 5 ~g/ml  20  30 
Cytochalasin D 5 ~g/ml  42  44 
+  colchicine, 10 -4 M 
After exposure to FITC-anti-Ig (50/~g/5  x  10  e cells in 0.5 ml for 20 min at 
4°C followed by washing), cells were capped for 20 min at 20°C before the 
addition of Cytochalasin B or D. Cells were incubated a further 20 rain 
at 20°C before termination of  the reaction. One set of  cells was incubated 
with 10  -4 M colchicine for 1 h at 37°C, cooled to 20°C, and exposed to 50 
~g/FITC-anti-Ig/5 ×  10  ~ cells in 0.5 ml at 20°C. The procedure was then 
identical  to  the  above.  Results  are  expressed as  percentage of 200 
positively stained cells with caps covering less than one-half  of the cell 
surface. Colchicine alone has no inhibitory effect on caps. 
FIG.  6.  Fig. 6 A and a are the phase contrast and fluorescent micrographs, respectively, of 
a normally capped cell after 40 rain at 20°C. Note the ameboid morphology with a rounded 
pseudopod and an apparent constriction occurring under the cap, in contrast to the adjacent, 
round lymphocyte. Fig.  6  B  and C  are cells in phase contrast that were allowed to cap 
normally for 20 rain at 20°C, but which were then exposed to oligomycin, 2/~g per ml. Note 
the exaggerated morphology with  a  severely constricting band  encircling the  cell  and 
bounded by the capped complexes, seen in fluorescent staining in  Fig.  6  b  and  c.  The 
cytoplasm in front of  the cap appears to be splayed out. Cells exposed to metabolic inhibitors 
before addition of  FITC-anti-Ig remain in a round configuration and are unable to cap (5). 28  CALCIUM  EFFECTS  ON  CAPPING 
accompanied by investigations suggesting this system to be actomyosin-like in 
its ATP-dependent, calcium-mediated mechanisms for the development of shear- 
ing force (11, 22, 28-30). We suggest that, in ligand-stimulated capping, there is 
a  continuous,  physical  relationship  between  surface  Ig,  or  transmembrane 
molecules linked with surface Ig, and calcium-responsive cytoplasmic microfila- 
ments that underlie and perhaps attach to the membrane. 
Two possibilities exist with respect to this link over time. Either the surface Ig 
molecules are already bound to the filaments or some component of them or this 
linkage occurs subsequent to the stimulation of complexing with a  ligand.  The 
mass of data underlying Singer and Nicholson's hypothesis (31) concerning the 
random  nature  of protein molecules in biological membranes  and the  lack of 
associated molecules on Ig isolated from the surface of lymphocytes (reviewed in 
Reference 32) weighs against this possibility. One can make a stronger case for 
the existence of a cytoplasmic-surface point linkage occuring after the binding of 
a ligand to that point, represented here by Ig. This concept offers the advantage 
of allowing nonrandomness to occur over time and not just in space. The ligand- 
receptor complex on the surface linked to the assembled microfilament network 
of the  cell  cortex  is  then  displaced  as  the  latter  system  contracts.  For  the 
contraction to be effective in producing a  cap, we suggest that it necessitates 
beth the relaxation of adjacent filaments as well as a mechanism for orientation 
and focusing of the contraction to one area or point of the membrane.  Underly- 
ing the  cap  should  be an  area  of activated  microfilaments  which  retains  its 
intercalations to the surrounding network of relaxed elements. We interpret the 
potent inhibition  of capping  by a  calcium  influx  due  to the  stimulation  of a 
generalized contraction forcing the cell to remain round and functionally immo- 
bilizing the surface complexes by preventing the simultaneous development of 
areas of contraction and relaxation necessary for net displacement of the com- 
plexes. Similarly,  such a  calcium-stimulated contraction would put tension on 
the formed cap,  stabilized  by underlying,  attached,  activated  microfilaments 
intercalated  with a  surrounding  network of heretofore relaxed filaments,  and 
pull it in all directions. 
To envision a chain of specialized microfilament contractions and relaxations 
moving  a  molecule within  and  through  the  membrane,  we must postulate  a 
sequence of activation, an activated contraction running beneath the membrane 
along the path of the moving cluster of molecules. What would be the source of 
activation,  in  light  of the  fact  that  extracellular  calcium  is  apparently  not 
required for either capping or movement? Ongoing experiments in this labora- 
tory have demonstrated the triggering of an efflux of calcium upon the addition 
of anti-Ig to the cell. One could conclude that the cell has intracellular  sites for 
storage of calcium to be released in the proper circumstances (33,  34).  Alterna- 
tively, calcium strongly bound to the membrane could be released into the cell 
by membrane  depolarization,  as has been suggested,  for smooth muscle  (35). 
Thus, a role for calcium release at a local spot may be operative in activating the 
driving force for capping. 
In studies  emphasizing  the capping of Con A  (12,  21),  de Petris first called 
attention  to  the  phenomenon  of cap  disruption.  He  has  envisioned  Con  A 
capping  to  involve  a  countercurrent  effect  with  noninvolved  areas  moving GEORGE  F.  SCHREINER  AND  EMIL  R.  UNANUE  29 
actively away from the fixed complexes. Extrapolating from the data on Con A 
caps and on the synergistic effects of cytochalasin B and colchicine on Ig caps 
(12), de Petris has concluded that the disruption of both Con A  and Ig caps 
involves the retraction of the actively moving part of the cell into the capped 
zone, with elements of the cap mixing with unlabeled membrane. We agree fully 
with his interpretation of Con A capping, but feel that the evidence suggests 
that the formation and disruption  of Con A  and anti-Ig caps  involve quite 
different processes: (a) Con A caps can be disrupted by drugs that affect energy 
metabolism (12, 21), while these  drugs  will  not  affect the  anti-Ig caps;  (b) 
capping of Con A is highly sensitive to cytochalasin B in contrast to the anti-Ig 
capping (12); and (c) time-sequence morphological studies differ, Con A  caps 
necessarily form in cells in movement (12, 21, 22), while, as shown herein, anti- 
Ig caps form first, before the establishment of gross cell contractions. With its 
multivalent binding and strict dosage requirements, Con A could be inducing 
any number of effects: locking of surface complexes bound to microfilaments, 
altering calcium physiology, preventing the establishment of a focusing point 
for filamentous contractions, or enhancing microtubular functions (9). We sug- 
gest,  however,  that  Ig  cap  formation is  fundamentally different and  that, 
reflecting this difference, disruption of the Ig caps, whether by A-23187 or by 
ctyochalasin D, is not a passive consequence of inhibiting intracellular elements 
(21), but rather,  is  an  active phenomenon requiring energy and continuous 
interaction between contractile elements in the cytoplasm and the complexed Ig 
receptors in the membrane. 
Summary 
Capping  of anti-Ig-Ig  complexes was  studied  in  murine  B  lymphocytes. 
Morphological studies indicated that caps formed rapidly on cells before any 
changes in shape. The first changes in cell shape were evident as a contraction 
right under the cap area. The removal of extracellular calcium had no effect on 
cap formation. Furthermore, the introduction of calcium by the ionophore A- 
23187 stopped capping. The ionophore by itself in the absence of extracellular 
calcium had no effect. Caps were found to be disrupted, the complexes scattering 
over the entire cell surface if the cells were treated by A-23187 after the caps had 
formed. The disruptive effect of A-23187 as dependent on extracellular calcium 
and could be stopped by drugs that affected energy metabolism. The cytochalas- 
ins also disrupted the formed caps.  Drugs that affect energy metabolism by 
themselves did not disrupt the caps. We interpret the effects of the ionophore as 
resulting from a  systemic hypercontractility of microfilaments. A  theory for 
explaining the formation and disruption of capping is discussed. 
We thank Mrs. Barbara Teixeira for excellent secretarial work. 
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